Cobb, L. P., Secord, A. A., Jiang, C., Zhang, D., Gaillard, S., Berchuck, A., … Siamakpour-Reihani, S. (2017). Differential expression of immune-related genes in high-grade ovarian serous carcinoma (HGSC): A platform for drug and biomarker discovery. In Gynecologic Oncology (Vol. 145, pp. 36–37). Elsevier BV. https://doi.org/10.1016/j.ygyno.2017.03.095

Cobb, L. P., A. A. Secord, C. Jiang, D. Zhang, S. Gaillard, A. Berchuck, K. Owzar, A. Nixon, and S. Siamakpour-Reihani. “Differential expression of immune-related genes in high-grade ovarian serous carcinoma (HGSC): A platform for drug and biomarker discovery.” In Gynecologic Oncology, 145:36–37. Elsevier BV, 2017. https://doi.org/10.1016/j.ygyno.2017.03.095.

Cobb LP, Secord AA, Jiang C, Zhang D, Gaillard S, Berchuck A, et al. Differential expression of immune-related genes in high-grade ovarian serous carcinoma (HGSC): A platform for drug and biomarker discovery. In: Gynecologic Oncology. Elsevier BV; 2017. p. 36–7.

Cobb, L. P., et al. “Differential expression of immune-related genes in high-grade ovarian serous carcinoma (HGSC): A platform for drug and biomarker discovery.” Gynecologic Oncology, vol. 145, Elsevier BV, 2017, pp. 36–37. Crossref, doi:10.1016/j.ygyno.2017.03.095.

Cobb LP, Secord AA, Jiang C, Zhang D, Gaillard S, Berchuck A, Owzar K, Nixon A, Siamakpour-Reihani S. Differential expression of immune-related genes in high-grade ovarian serous carcinoma (HGSC): A platform for drug and biomarker discovery. Gynecologic Oncology. Elsevier BV; 2017. p. 36–37.